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Abstract
Background: Creatine (CR) is considered an effective nutritional supplement having ergogenic effects, which
appears more pronounced in upper-body compared to lower-body exercise. Nevertheless, results regarding the
impact of CR loading on repeated high-intensity arm-cranking exercise are scarce and in some cases conflicting.
Interestingly, few of the conducted studies have structured their research designs to mimic real world sporting
events. Therefore, our purpose was to address the hypothesis that CR ingestion would increase anaerobic power
output in consecutive upper-body intermittent sprint performance (UBISP) tests designed to simulate wrestling
matches on a competition-day.
Methods: In a double-blind, placebo-controlled, parallel-group study, 20 trained wrestlers were assigned to either
placebo or CR supplemented group (0.3 g ∙ kg−1 of body mass per day). Four 6-min UBISP tests interspersed with
30-min recovery periods were performed before (trial 1) and after 5 days (trial 2) of supplementation. Each test
consisted of six 15-s periods of arm-cranking at maximal executable cadence against resistance of 0.04 kg ∙ kg−1 body
mass interspersed with 40-s unloaded easy cranking periods and 5-s acceleration intervals (T1–T4). Mean power (MP),
peak power (PP), fatigue index and heart rate parameters were measured during UBISP tests. Also, body weight and
hydration status were assessed. Principle measures were statistical analysed with mixed-model ANOVAs.
Results: Mean individual CR consumption in the CR group was 24.8 ± 2.5 g ∙ d−1. No significant (P > 0.05) differences
occurred in body mass or hydration status indices between the groups or across trials. MP, PP and fatigue index
responses were unaffected by supplementation; although, a significant reduction in MP and PP did occurred from T1
to T4 in both trial 1 and 2 (P < 0.001). Overall heart rate responses in the tests tended to be higher in the CR than PLC
group (P < 0.05); but, trends in responses in trials and tests were comparable (P > 0.05).
Conclusion: These results suggest that 5-day CR supplementation has no impact on upper-body muscle anaerobic
power output in consecutive UBISP anaerobic tests mimicking wrestling matches on a competition day.
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Background
Creatine monohydrate is considered the most effective
nutritional supplement in terms of increasing lean body
mass and improving anaerobic performance [1]. Typical
recommended creatine supplementation regimen con-
sists of a loading phase of 20–25 g ∙ d−1 for 2–7 days,
followed by a maintenance phase of 2–5 g ∙ d−1
thereafter [1–6]. A meta-analysis of 96 published investi-
gations totaling 1847 subjects revealed that the effect of
creatine supplementation is more pronounced in
repetitive-bout than in single-bout exercise and in
upper-body performance tasks than in lower body exer-
cise [7]. Furthermore, the effect size for improvement in
performance in high-intensity exercise lasting ≤ 30 s is
greater than for tasks of longer duration, but no signifi-
cant differences occur in performance effect between
males and females or between trained athletes and un-
trained subjects [7].
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In wrestling, repetitive forceful muscle contractions
are required during most of sport’s maneuvers and the
upper-body anaerobic power of an athlete is consid-
ered an important factor influencing competitive suc-
cess [8, 9]. To this end, the findings of Branch [7]
suggest that wrestlers may benefit from creatine sup-
plementation, but surprisingly there are only a few
previous studies which have examined the impact of
creatine on physical performance indices in competi-
tive wrestlers. Nevertheless, Koçak and Karli [10]
demonstrated significant increases in mean power and
peak power attained in a 30-s Wingate test after com-
pared to before creatine supplementation in elite male
Turkish wrestlers. Ziegenfuss et al. [11] studied elite
male and female power athletes, including eight male
wrestlers, and demonstrated significant improvement
in repeated cycling sprint performance following
short-term creatine supplementation. Ööpik et al. [12]
found that creatine supplementation during 17-h re-
covery from rapid body mass loss stimulated the re-
gain of physical working ability in a performance test
simulating wrestling match in well-trained wrestlers.
The limitations in the data regarding the impact of
creatine supplementation on physical performance in
trained wrestlers are due to studies employing non-
wrestling-specific test protocols [10, 11] or use ex-
tremely limited sample sizes (n = 5) [12]. A wrestling
tournament usually lasts for many hours and in order to
win a wrestler has to defeat on average four to five op-
ponents. Whether creatine supplementation helps a
wrestler to better maintain the ability to perform power-
ful actions throughout a tournament situation is not
known.
Therefore, the aim of this study was to examine the in-
fluence of creatine monohydrate loading on upper-body
intermittent sprint performance (UBISP) across four
consecutive tests mimicking four wrestling matches on
the same day. Considering the proved positive impact of
creatine on performance in repeated high-intensity
upper-body exercise in trained athletes [7], we hypothe-
sized that creatine use compared to placebo would in-
crease upper-body anaerobic power in trained wrestlers.
Methods
Subjects
Twenty healthy, male, amateur level Brazilian Jiu Jitsu
and Submission Wrestling athletes participated in this
study. The research protocol, which conforms to the
ethical guidelines of the Declaration of Helsinki of the
World Medical association, was approved by the Re-
search Ethics Committee of the University of Tartu,
Estonia (reference No 229/T-17). Written informed con-
sent was obtained from the athletes prior to their par-
ticipation in the study. All wrestlers trained at a local
combative sports club and had a minimum of three
years of regular wrestling training and two years of com-
petition experience. During participation in the study,
the athletes followed their usual training regimen. They
did not participate in any competition or practiced any
bodyweight control or cutting procedures. Their training
volume was 6–8 h (3–4 2-hour sessions) per week. Each
session included a combination of calisthenics exercises,
technical and tactical drills, and training matches. Partic-
ipants (mean ± SD) age, body mass, height and body fat
percentage were 25.6 ± 3.8 years, 82.7 ± 8.6 kg, 185.1 ±
6.5 cm and 16.1 ± 2.4 %, respectively.
Study design
The participants underwent two phases (preparatory and
main) in this double-blind, placebo controlled study. In
the preparatory phase, two visits, 2–3 days apart were
made to the laboratory. During these visits the partici-
pants were familiarized with the testing devices and pro-
cedures and on both occasions a single familiarization
UBISP test was performed. In the main phase of the
study, the participants were divided into creatine (CR; n
= 10) and placebo (PLC; n = 10) groups by listing their
initial body mass from the lowest to the highest and
then assigning them to alternate groups. There were no
statistically significant differences between the groups
for age, height, body mass or percentage of body fat.
Both groups underwent two simulated competition days
with exactly seven days in-between. The first simulated
competition day (trial 1) was completed without any
prior dietary supplementation. The second simulated
competition day (trial 2) was completed after 5-day cre-
atine monohydrate (CR group) or placebo (PLC group)
supplementation period.
Upper-body intermittent sprint performance test
The UBISP test protocol employed was a modification
of that developed specifically for assessing upper body
anaerobic performance in wrestlers [13]. The modified
protocol was described in details by Aedma et al. [14]
and it has been previously used for assessing the poten-
tial impact of different dietary supplements on physical
performance in wrestlers [14, 15]. In brief, a cycle erg-
ometer (Monark® Ergomedic 894 E, Monark, Sweden)
with the pedals replaced by handgrips was employed.
The UBISP test was 6-min, performed in a seated pos-
ition and consisted of six separate 15-s bouts of arm-
cranking exercise at maximal executable cadence against
resistance of 0.04 kg · kg−1 body mass interspersed with
40-s unloaded easy cranking periods and 5-s acceleration
intervals. Peak power (PP) and mean power (MP) for
each 15-s bout of maximal effort was calculated by com-
puter software (Monark, Sweden). Percent decrease in
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power (fatigue index) was calculated as following:
[(PP—PPbout6)/PP] × 100.
Simulated competition day
The participants were instructed to abstain from any
training loads for 24 h prior to both trial 1 and trial 2.
The participants reported to the laboratory after break-
fast, approximately 9:00 in the morning. The sequence
of procedures carried out on a trial day (i.e. simulated
competition day) are shown in Fig. 1. Upon arrival, the
participants provided a urine sample and their body
mass was measured to the nearest 0.001 kg (CH3G-150I
Combics scale, Sartorius, Germany). The participants
then sat behind the cycle ergometer for 20 min. Five mi-
nutes prior to the first UBISP test of the day, they
warmed up by performing a 3-min unloaded arm-
cranking exercise at a self-selected pace. Then, after 2-
min rest, participants accomplished four 6-min UBISP
tests (hereinafter: T1, T2, T3 and T4) with 30-min
recovery periods between the consecutive tests. During
recovery, for the first 5 min following an UBISP test, the
participants remained seated behind the ergometer. Dur-
ing the subsequent 10 min the participants could walk
around in the laboratory, visit the toilet or rest in a self-
selected position. In minutes 15–25 the participants
rested quietly in a supine position on a couch. For the
last 5 min of the recovery period the participants took a
seat on the chair behind the ergometer and performed a
3-min warm-up by unloaded arm-cranking at a self-
selected pace. Finally the participants remained seated
and rested for the last 2 min of the recovery period. The
ratings of perceived fatigue (RPF) and perceived exertion
(RPE) were recorded immediately before and after each
UBISP test, respectively. Both RPF and RPE in this study
were measured using Borg’s 10-point scale [16]. After
T2, during the 2nd recovery phase, the participants
drank 0.5 L of sports drink Arctic Sport (A Le Coq,
Estonia). During all the three recovery periods, the par-
ticipants could drink water ad libitum and the individual
quantities consumed were recorded. If they used the
toilet, the participants were asked to collect all urine
into a container.
Creatine and placebo supplementation
The supplementation was initiated on the second day
after trial 1 and lasted for five days prior to trial 2. Dur-
ing the supplementation period the CR group ingested
creatine monohydrate (Creapure®, distributed by FAST
Sports Nutrition, Func Food Finland OY, Finland) and
the PLC group consumed glucose (Trauben Zucker,
Müller’s Mühle GbmH, Germany). Both supplements
were administered in gelatine capsules in a quantity of
0.3 g ∙ kg−1 of body mass per day. Daily dose of both
supplements was divided into four equal portions and
participants were instructed to consume these portions
throughout a day, approximately 4 h apart. The creatine
monohydrate supplementation protocol employed in the
current study has been shown to induce significant in-
creases in muscle total creatine content [17–19]. During
the supplementation period the participants followed
their routine training regimen and kept detailed food
diary. Later analysis of these diaries revealed a 100 %
compliance with ingesting of the supplements.
Blood sampling and analyses
Altogether six fingertip capillary blood samples were
drawn from each participant during both trial 1 and trial
2. To measure changes in plasma volume across the four
consecutive UBISP tests, one sample was drawn immedi-
ately before T1 and another one after T4. Haemoglobin
concentration and haematocrit were measured using a
Celltac α MEK-6108 K (Nihon Kohden, Japan) blood
analyser. The haemoglobin and haematocrit data were
used for calculation of relative changes in plasma vol-
ume [20]. Blood lactate concentrations were measured
in samples taken immediately before T1 and T4 (Pre-Ex)
and 4 min after T1 and T4 (Post-Ex). Blood lactate con-
centration was measured using Dr. Lange cuvette tests
LKM 140 and miniphotometer LP 20 Plus (Dr. Lange,
Germany).
Fig. 1 The sequence of procedures carried out during a simulated competition day. T1–T4—upper-body intermittent sprint performance tests;
BM—body mass; BL—blood sample; USG—urine specific gravity; HRER—early recovery heart rate; HRLR—late recovery hear rate
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Heart rate monitoring
Heart rate (HR) was monitored using standard Suunto
HR belt (Suunto Oy, Finland) and recorded to a desktop
computer using Suunto Monitor software (version 1.1.2
Suunto Oy, Finland). HRPEAK was the highest HR value
registered during UBISP test. Early recovery heart rate
(HRER) was recorded at the end of the 4th min of each
recovery period. Late recovery heart rate (HRLR) was
measured as the last 5 min average of the 10 min supine
position resting phase during the recovery periods fol-
lowing T1, T2 and T3.
Assessment of body composition and hydration status
Once following trial 1, before starting supplementation
period, the participants underwent DXA screening
(Lunar DPX IQ, Lunar Corp, USA) to determine their
body composition.
Two urine samples for the assessment of hydration
status were collected from the participants in both trial
1 and trial 2: before T1 and after T4. Urine specific grav-
ity (USG) was measured using digital clinical refractom-
eter PDX-CL (VEE GEE Scientific, Inc., Kirkland, WA).
Additionally, the volume of urine passed was measured
for the time interval from donation of the first urine
sample till the end of the simulated competition day.
Water retention was calculated as difference between
the volumes of water consumed and urine passed.
Statistical analysis
The Statistica™ version 12 software was used for statis-
tical analysis. All data are expressed as mean ± SD. Nor-
mality of all data sets was examined using the
Kolmogorov-Smirnov test. The effect of creatine inges-
tion on performance (PP, MP, fatigue index), heart rate
(HRPEAK, HRER, HRLR), RPE and RPF was assessed using
3-way mixed model ANOVA (between-factor—group,
within factors—trial and test). The blood lactate data
were analyzed with 4-way mixed model ANOVA (be-
tween-factor—group, within factors—trial, test, and pre-
and post-performance test). Body mass data were ana-
lyzed using 3-way mixed model ANOVA (between-fac-
tor—group, within factors—trial and time). Hydration
data were analyzed using 2-way mixed model ANOVA
(between factor—group, within factor—trial). The nutri-
tional data were analyzed using Student’s t-test for inde-
pendent variables. In all analyses, where a significant
effect was observed, a Tukey’s HSD post-hoc was used
to identify specific differences. Statistical significance
was set at P < 0.05.
Results
Energy, macronutrients and water consumption
During the 5-day supplementation period the self-
reported daily energy intake of the participants was
2703 ± 780 kcal in PLC group and 2362 ± 454 kcal in CR
group. In PLC group, the total daily energy intake was
made up of carbohydrates, proteins and fats in propor-
tions of 38.7 ± 13.5 %, 19.9 ± 6.4 %, and 41.5 ± 11.3 %, re-
spectively. In CR group carbohydrates, proteins and fats
contributed to the total energy intake by 35.6 ± 7.4 %,
18.1 ± 3.1 % and 45.6 ± 7.0 %, respectively. The self-
reported daily water consumption was 2481 ± 906 ml in
PLC group and 2250 ± 1003 ml in CR group. There were
no statistically significant between-group differences in
any of the nutritional parameters assessed (P > 0.05).
Mean daily CR consumption of the participants in the
CR group was 24.8 ± 2.5 g.
Body mass and hydration status
Body mass and hydration status indices are presented in
Tables 1 and 2, respectively. There were no significant
(P > 0.05) differences in body mass between the supple-
mentation groups, within the two trials, or in relation to
before T1 and after T4.
All hydration indices USG, urine volume, water intake
and water retention display similar responses to body
mass. That is, there were no significant (P > 0.05) differ-
ences in hydration indices between the supplementation
groups, within the two trials, or in relation to tests (i.e.
USG before T1 and after T4).
Finally, calculated plasma volume shifts did not differ
significantly (P > 0.05) between supplement groups or
across trials.
Upper body intermittent sprint performance and fatigue
index
Figure 2 depicts the changes in PP and MP for each
group in both trials and across all tests (T1–T4). The
only significant finding in this data was that for both PP
and MP there was a significant reduction (P = 0.001 and
P < 0.001, respectively) due to exercise (main effect) from
T1 to T4. No effects due to supplement group or trial
were detected. In both CR and PLC groups, six partici-
pants attained greater and four participants smaller PP
(average for four tests) after compared to before supple-
mentation period. The ranges of individual improve-
ments in average PP in CR and PLC groups were 3.3–
20.9 W and 6.2–20.6 W, respectively. The ranges of indi-
vidual decrements in average PP in CR and PLC groups
Table 1 Body mass (kg)
Placebo (n = 10) Creatine (n = 10)
Trial 1 Trial 2 Trial 1 Trial 2
Before T1 82.64 (9.36) 82.49 (9.31) 82.73 (8.38) 82.46 (8.65)
After T4 82.87 (9.36) 82.66 (9.41) 82.76 (8.13) 82.53 (8.38)
Change 0.23 (0.43) 0.17 (0.32) 0.03 (0.52) 0.06 (0.58)
Data are presented as mean (SD). T1 and T4—upper-body intermittent sprint
performance tests
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were 2.2–10.7 W and 2.8–10.5 W, respectively. Regard-
ing MP (average for four tests), five participants in CR
group and six participants in PLC group revealed im-
provements after compared to before supplementation
period in the ranges of 1.0–26.4 W and 1.2–23.1 W, re-
spectively. Average MP decreased in five participants in
CR group (range 1.7–24.0 W) and in four participants in
PLC group (range 1.5–15.1 W). Fatigue index responses
displayed no significant (P > 0.05) changes (data not
reported).
Blood lactate concentration
Lactate responses are displayed in Fig. 3. Post-
exercise significant increases in lactate occurred in T1
and T4 for both the PLC and CR groups (i.e., main
effect). Additionally, the Pre-Ex lactate concentrations
at T4 for trial 1 and trial 2 were significantly greater
than in T1 (P values range: 0.0002–0.003).
Heart rate
All forms of HR response measurements are reported in
Table 3. The CR group had significantly greater overall
HRPEAK (P = 0.017) and HRER (P = 0.043) response com-
pared to PLC group. Furthermore, for tests the HRER
and HRLR significantly decreased overall (P values
0.00002 and 0.03, respectively).
Ratings of perceived fatigue and exertion
The RPF and RPE results are reported in Table 4. For
RPF, in the PLC group a significant (P < 0.001) increase
fatigue occurred in trial 1 and 2. In trial 1 T2, T3 and
T4 were significantly greater than T1; and, in trial 2 T3
and T4 were significantly greater than T1. In the CR
Table 2 Hydration indices
Parameter Placebo (n = 10) Creatine (n = 10)
Trial 1 Trial 2 Trial 1 Trial 2
USG before T1 1.0220 (0.0061) 1.0194 (0.0084) 1.0167 (0.0069) 1.0216 (0.0075)
USG after T4 1.0197 (0.0048) 1.0184 (0.0041) 1.0184 (0.0029) 1.0192 (0.0036)
Urine volume (ml) 194 (95) 240 (100) 281 (141) 291 (250)
Water intake (ml) 1033 (427) 955 (322) 1003 (418) 1047 (428)
Water retention (ml) 839 (431) 716 (341) 723 (431) 757 (439)
Change in PV (%)
Before T1→ After T4 −2.69 (5.13) −3.59 (5.69) −4.63 (4.80) −1.82 (4.80)
Data are presented as mean (SD). Urine volume, water intake and water retention were measured for the time interval between before T1 and after T4. USG urine
specific gravity; PV plasma volume; T1 and T4—upper- body intermittent sprint performance tests
Fig. 2 Peak power (a, b) and mean power (c, d) attained during upper-body intermittent sprint performance tests T1–T4 before (trial 1) and after
(trial 2) 5-day supplementation period. The columns represents average ± SD peak and mean power values for six 15-s bouts of maximal effort
performed during the test. In both placebo and creatine groups the number of subjects is 10
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group the only significant change in RPF was in trial 2
where T4 was greater than T1.
The only significant (P < 0.05) change in RPE occurred
in trial 1 for both the PLC and CR groups. The T4 re-
sponses in both of these situations were greater than T1
showing an increase in effort.
Discussion
The main finding of this study was that short-term creat-
ine supplementation had no impact on PP or MP attained
by trained wrestlers during consecutive anaerobic tests
intended to mimic a typical competition-day in wrestling.
Furthermore, creatine did not influence fatigue develop-
ment substantially relative to the placebo. To the best of
our knowledge, this is the first study assessing the poten-
tial efficacy of creatine loading in improving upper-body
anaerobic performance in combative-type sports under a
simulated competition setting. Previous studies focusing
on wrestling scenarios have demonstrated ergogenic ef-
fects of creatine supplementation in participants, but as
noted earlier these studies have limitations [10–12].
Our hypothesis that creatine loading would increase
upper-body anaerobic power was based on the out-
comes of meta-analytic and systematic literature
reviews. These reviews revealed that creatine supple-
mentation has the most pronounced positive effect on
performance in multiple bouts of high-intensity,
short-duration exercise [2, 4, 7, 21, 22] and that gen-
erally the effect of creatine on performance is greater
in upper-body exercise than in lower-body exercise
[7]. Regarding intermittent sprint performance in ex-
ercise tasks loading lower-body musculature, marked
improvement following short-term creatine supplementa-
tion has been reported by numerous research groups in
untrained and moderately trained subjects [23–29] as well
as in highly trained athletes [11, 30–35]. Not all of the
relevant studies, however, have confirmed the ergogenic
effect of creatine loading [36–40]. Furthermore, to the
best of our knowledge, only two research groups [41, 42]
have assessed the potential impact of short-term creatine
Fig. 3 Blood lactate in upper-body intermittent sprint performance
(UBISP) tests T1 and T4 before (a) and after (b) 5-day supplementation
period. Data are presented as means ± SD for 10 subjects in both
placebo and creatine groups. Pre-Ex—immediately before UBISP test;
Post-Ex—4 min after UBISP test. Significantly different (P < 0.05): * from
Pre-Ex: # from T1
Table 3 Heart rate (bpm)
Test Placebo (n = 10) Creatine (n = 10)
HRPEAK HRER HRLR HRPEAK HRER HRLR
Trial 1
T1 165 (9) 105 (11) 80 (10) 172 (11) 115 (15) 87 (13)
T2 164 (7) 104 (11) 80 (8) 172 (8) 114 (15) 86 (13)
T3 165 (7) 101 (9) 76 (9) 172 (6) 110 (15) 85 (12)
T4 165 (6) 98 (9) a ― 174 (7) 106 (15) a ―
Trial 2
T1 163 (8) 101 (8) 78 (10) 171 (9) 115 (15) 85 (14)
T2 164 (5) 102 (9) 77 (7) 172 (9) 115 (14) 85 (15)
T3 162 (5) 100 (8) 74 (8) 171 (8) 111 (13) 84 (14)
T4 165 (6) 100 (8) ― 173 (8) 112 (12) ―
Data are presented as mean (SD). HRPEAK peak heart rate; HRER early recovery
heart rate; HRLR late recovery heart rate; T1–T4—upper-body intermittent
sprint performance tests
a Different from T1, P < 0.05
Table 4 Ratings of perceived fatigue (RPF) and perceived
exertion (RPE)
Test Placebo (n = 10) Creatine (n = 10)
Trial 1 Trial 2 Trial 1 Trial 2
RPF T1 1.1 (0.8) 0.9 (0.7) 1.8 (0.9) 1.3 (1.1)
T2 1.9 (1.1) a 1.9 (1.2) 2.2 (0.8) 1.8 (1.1)
T3 2.0 (1.3) a 1.9 (1.0) a 2.3 (0.8) 1.9 (1.1)
T4 2.0 (1.0) a 2.3 (0.9) a 2.5 (1.2) 2.3 (1.4) a
RPE T1 6.8 (2.1) 6.9 (1.7) 5.9 (1.7) 5.8 (1.7)
T2 7.2 (1.7) 7.6 (1.6) 6.3 (1.4) 6.2 (1.5)
T3 7.6 (1.7) 7.5 (1.5) 6.5 (1.4) 6.3 (1.6)
T4 8.1 (1.3) a 7.8 (1.2) 7.1 (1.5) a 6.6 (1.7)
Data are presented as mean (SD). T1–T4—upper-body intermittent sprint
performance tests. a Different from T1, P < 0.05
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supplementation on repeated high-intensity arm-cranking
exercise performance in athletes and the findings of these
studies were conflicting. Grindstaff et al. [41] reported
7.5 % greater peak power output during the first of three
consecutive 20-s arm ergometer maximal-effort sprint
tests after compared to before nine days of creatine mono-
hydrate (21 g ∙ d−1) ingestion in trained swimmers. Green
et al., however, found that six days of creatine supplemen-
tation (20 g ∙ d−1) did not enhance peak power or mean
power during three consecutive 30-s arm Wingate tests in
recreational athletes [42]. In addition, Jacobs et al. [43],
employing incremental peak arm ergometry test con-
sisting of 2-min work stages and 1-min recovery pe-
riods, observed a significant increase in peak power
output (6.7 %) following seven days of creatine sup-
plementation (20 g · day−1) in men with complete
cervical-level spinal cord injury.
Taken together, the limited and inconsistent literature
and the current findings are clearly insufficient to draw
any definitive conclusions regarding the influence of
short-term creatine supplementation on anaerobic per-
formance in arm-cranking exercise. Therefore, further
studies are warranted in order to better elucidate the po-
tential impact of creatine on performance in this par-
ticular mode of physical activity.
In our participants, creatine loading had no influence
on body mass. According to Branch et al. [7], approxi-
mately 64 % of studies which have measured body mass
and/or body composition have reported statistically sig-
nificant increases in body mass or lean body mass due
to creatine supplementation. Regarding short-term creat-
ine monohydrate loading in particular, a review con-
ducted by Volek and Kraemer [44] revealed that
ingestion of 20–30 g of this substance per day for five to
seven days usually induces an increase in body mass in
the range of 0.9–1.8 kg. Kilduff et al. [45] reported posi-
tive correlation between change in body mass and
whole-body creatine uptake. Saab et al. [46] suggested
that an increase in intracellular muscle water may occur
due to osmotic properties of creatine and this may be re-
sponsible for the rapid change in body mass accompany-
ing creatine use. Therefore, some authors [28, 34] have
interpreted increase in body mass as an indirect evi-
dence of successful muscle creatine loading.
The absence of any change in body mass or hydration
in our subjects during the supplementation period does
not necessarily, however, indicate that creatine ingestion
failed to increase muscle creatine content. Some reports
indicate body mass actually does not correlate with in-
creases in muscle creatine content [18] or in the muscle
phosphocreatine/ATP ratio [46]. Furthermore, short-
term creatine supplementation has been shown to
improve performance in high-intensity arm-cranking ex-
ercise [41], cycling sprints [25, 27, 29], maximal
unilateral knee extension and maximal deadlift strength
[47] and to increase anaerobic running capacity [48]
without concomitant changes in body mass.
Creatine ingestion did not influence blood lactate re-
sponse to the anaerobic tests in our participants. The
potential effect of creatine on blood lactate levels in re-
peated high-intensity arm-cranking exercise has not
been reported, but blood lactate response to repeated
running or cycling sprints have been shown to be un-
changed [25, 34], increased [26, 35], or decreased [23, 31]
when compared to before creatine loading.
HRPEAK and HRER were consistently higher in CR than
PLC group. The reason for this finding is unclear, but
the data clearly reveal that supplements ingested (creat-
ine and placebo) had no impact on HR during the
UBISP tests or during recovery periods between the con-
secutive UBISP tests in our participants. Regarding
HRPEAK, our findings are consistent with that reported
by Jacobs et al. [43], who observed similar peak HR
values before and after creatine loading in cervical cord
injury patients performing incremental peak arm ergo-
metry test. Others have reported no effect of creatine on
exercise heart rate in repeated running [32, 33] or cyc-
ling [27] sprints or lower average heart rate during re-
peated running sprints after compared to before creatine
loading [31], or during recovery [27].
There was no substantial and consistent effect of cre-
atine or placebo supplementation on the RPF or RPE re-
sponses to the UBISP tests. This finding suggests that
creatine loading did not strongly influence perception of
effort during the tests or subjective feeling of recovery
between the consecutive tests. Jacobs et al. examined
RPE during arm-cranking exercise and reported similar
RPE values in creatine and placebo exercise trials [43].
However, as significantly greater peak power output was
attained after creatine loading compared to placebo, the
RPE data [43] suggest that creatine actually attenuated
the perception of effort in their subjects.
An acknowledged methodological limitation of this
study is the absence of direct evidence confirming that
creatine loading increased muscle creatine content in
our subjects. Considering that the extent of creatine up-
take during supplementation period appears to be crit-
ical to subsequent performance in repeated bouts of
high-intensity exercise [17, 19], failure to increase
muscle creatine content would explain the lack of any
change in upper body anaerobic power. However, we are
confident in the high quality of the creatine product and
our subjects complied with supplement use based upon
food diary reviews and in direct questioning of them in-
dividually. The potential influence of participation in
routine wrestling training sessions on muscle creatine
content in our subjects is difficult to evaluate, because
exercise has been demonstrated to increase [49, 50],
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have no impact [51] or decrease [52] muscle creatine ac-
cumulation during loading period. Nevertheless, we can-
not completely exclude the possibility that a longer
supplementation period might have been needed for oc-
currence of an ergogenic effect. Vandenberghe et al. [53]
and Francaux et al. [54] administered similar daily dos-
ages of creatine (20 g and 21 g) to their subjects for 4 or
14 days, respectively. While both groups reported signifi-
cant increases in muscle phosphocreatine content fol-
lowing supplementation period, the extent of the
increase was much smaller (approximately 5 %) after
4 days [53] compared to that observed after 14 days (ap-
proximately 20 %) [54].
The exercise protocol employed was developed to be
in line with a “real world” situation for mimicking wrest-
ling matches during a competition-day and hence prac-
tical. On the other hand, the specificity of the exercise
protocol may have diminished the potential ergogenic
effect of increased muscle creatine content in our sub-
jects. Improved performance in repeated bouts of high-
intensity exercise following creatine loading is likely due
to an increased pre-exercise creatine phosphate availabil-
ity and enhanced resynthesis of phosphocreatine during
recovery periods [17, 23, 24]. However, it has been dem-
onstrated that the rate of resynthesis of phosphocreatine
is practically identical in creatine-loaded and non-loaded
muscle during the initial 40 s after intense exercise,
whereas the accelerated resynthesis mainly occurs dur-
ing the 2nd minute of recovery [18]. While phospho-
creatine resynthesis depends on muscle oxygen supply
and removal of lactate and protons [55], i.e. processes
which largely are based on diffusion [56], the 40-s
unloaded easy cranking periods (active recovery inter-
vals) between consecutive 15-s maximal exercise bouts
may be too short to elicit enhanced phosphocreatine re-
synthesis in creatine-loaded state. Further, high-intensity
upper-body exercise relies much more on the anaerobic
lactic energy system than lower-body exercise [57, 58],
but the diffusional area is smaller and the diffusional dis-
tance longer in the arm than in the leg muscles [59].
Therefore, occurrence of the potential ergogenic effect
of creatine loading in repeated bouts of high-intensity
arm-cranking exercise may require longer between-bout
recovery intervals than those used in the current study
or in the other relevant studies [41, 42].
Conclusion
Five days of creatine monohydrate supplementation
failed to increase upper-body anaerobic power in an-
aerobic tests mimicking wrestling matches in trained
wrestlers. Considering the great practical importance
of upper body muscular performance not only for
combat sports athletes but also for disabled people
who use wheelchair in their everyday life, further
studies in this area of interest are warranted.
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